Step by Step Therapy, Inc.

02/23/2026

Life really can take the wildest turns once you put your hand on the wheel and detach yourself from the mentality of a victim. Become a warrior. You can use your suffering to become successful. Allow that pain to manifest as something powerful and unrelenting. You see my posts , you hear the music… Most of you just know the SINGER doing well. But I can never put into words how dark it was for the Man behind the music videos … for many years I surrendered to my pain. I’m not immune to it, but when it strikes, I counter now. Because I’m worth the fight. God Bless. Love ya’ll… thanks for helping me realize things about myself I couldn’t see ♥️🥹 🎶

02/23/2026

02/22/2026

02/21/2026

IVERMECTIN:Broad-Spectrum Anticancer Potential

(Open picture to see all)

Documented tumor suppression and inhibitory effects have been observed across multiple oncological areas (Reference: PMC7505114):

➡️Gastrointestinal: Colorectal and Pancreatic cancers.

➡️Hormonal: Breast, Ovarian, and Prostate cancers.

➡️Respiratory: Non-small cell lung cancer (NSCLC).

➡️Neurological: High-grade Glioblastomas (Brain Cancer).

➡️Hematological: Leukemia and Lymphoma.
- STAT3 signaling inhibition.

A comprehensive clinical review suggests a significant paradigm shift in modern oncology.

While widely recognized for its safety profile over four decades, Ivermectin is now demonstrating potent effects across an extensive range of malignant cell lines. This is no longer just observational data; it is molecular science.

Core Molecular Mechanisms:

Unlike single-target therapies, Ivermectin appears to exert its anticancer effects through a sophisticated, multi-front attack on the disease:

1️⃣ Transcriptional Inhibition: It effectively targets and suppresses key signaling pathways, including Wnt/β-catenin, STAT3, and mTOR, which are frequently overexpressed in aggressive, treatment-resistant tumors.

2️⃣ Induction of Immunogenic Cell Death: By promoting ROS (Reactive Oxygen Species) stress and mitochondrial dysfunction, Ivermectin triggers apoptosis (programmed cell death) while simultaneously enhancing the host's natural antitumor immune response.

3️⃣ Targeting Cancer Stem Cells (CSCs): Compelling evidence suggests Ivermectin may inhibit the "roots" of tumor recurrence, potentially addressing the critical challenge of metastasis and therapy resistance.

The Clinical Gap: Despite these compelling molecular findings, large-scale clinical trials for these off-patent applications remain critically underfunded. 💸